◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Marvel Biosciences Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q4 2025Oct 31, 2025 Q3 2025Jul 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00 0.00
Cost Of Revenue 57,457 250,559 382.00 285,002 11,423
Gross Profit -57,457 -250,559 -382.00 -285,002 -11,423
Selling General And Administration 195,377 229,080 240,710 241,213 209,802
General And Administrative Expense 195,377 229,080 240,710 241,213 209,802
Other Operating Expenses 10,523 -131,652 34,229 -132,820 10,755
Operating Expense 205,900 97,428 274,939 108,393 220,557
Operating Income -263,357 -347,987 -275,321 -393,395 -231,980
EBIT -285,863 -1.0M -222,759 -449,811 -242,457
Interest Expense 56,400 161,771 34,652 35,795 35,788
Interest Expense Non Operating 56,400 161,771 34,652 35,795 35,788
Interest Income -- 72.00 1,862 -- --
Interest Income Non Operating -- 72.00 1,862 -- --
Net Interest Income -56,400 -161,699 -32,790 -35,795 -35,788
Other Income Expense -22,506 -680,520 50,700 -56,416 -10,477
Gain On Sale Of Security -22,506 -8,180 50,700 -56,416 -10,477
Pretax Income -342,263 -1.2M -257,411 -485,606 -278,245
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -342,263 -1.2M -257,411 -485,606 -278,245
Net Income From Continuing Operation Net Minority Interest -342,263 -1.2M -257,411 -485,606 -278,245
Net Income Including Noncontrolling Interests -342,263 -1.2M -257,411 -485,606 -278,245
Net Income Common Stockholders -342,263 -1.2M -257,411 -485,606 -278,245
Net Income -342,263 -1.2M -257,411 -485,606 -278,245
EBITDA -285,863 -1.0M -222,759 -449,811 -242,457
Normalized EBITDA -263,357 -947,915 -273,459 -393,395 -231,980
Basic EPS -0.01 -- -0.01 -0.01 -0.01
Diluted EPS -0.01 -- -0.01 -0.01 -0.01
Basic Average Shares 55.6M -- 46.7M 44.8M 44.8M
Diluted Average Shares 55.6M -- 46.7M 44.8M 44.8M
Total Unusual Items -22,506 -80,520 50,700 -56,416 -10,477
Total Unusual Items Excluding Goodwill -22,506 -80,520 50,700 -56,416 -10,477
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00
Normalized Income -319,757 -1.1M -308,111 -429,190 -267,768
Diluted NI Availto Com Stockholders -342,263 -1.2M -257,411 -485,606 -278,245
Net Income Continuous Operations -342,263 -1.2M -257,411 -485,606 -278,245
Net Non Operating Interest Income Expense -56,400 -161,699 -32,790 -35,795 -35,788
Other Gand A 95,578 125,490 123,412 128,949 102,862
Reconciled Cost Of Revenue 57,457 250,559 382.00 285,002 11,423
Salaries And Wages 99,799 103,590 117,298 112,264 106,940
Selling And Marketing Expense -- -- -- -- 17,750
Total Expenses 263,357 347,987 275,321 393,395 231,980
Line Item Q4 2025Oct 31, 2025 Q3 2025Jul 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024
Cash And Cash Equivalents 633,536 128,855 389,016 59,530 83,288
Cash Cash Equivalents And Short Term Investments 633,536 128,855 389,016 59,530 83,288
Cash Financial 633,536 128,855 389,016 59,530 83,288
Receivables 25,086 167,549 89,933 133,128 124,840
Prepaid Assets 24,434 30,311 21,563 26,417 20,517
Current Assets 683,056 326,715 500,512 219,075 228,645
Total Non Current Assets 0.00 0.00 0.00 0.00 0.00
Total Assets 683,056 326,715 500,512 219,075 228,645
Current Debt 2.3M 2.3M 1.0M -- --
Current Debt And Capital Lease Obligation 2.3M 2.3M 1.0M -- --
Accounts Payable 1.6M 1.5M 1.4M 1.7M 1.3M
Payables 1.6M 1.5M 1.5M 1.8M 1.4M
Payables And Accrued Expenses 2.0M 2.0M 1.7M 2.1M 1.6M
Current Accrued Expenses 417,019 522,649 251,069 216,932 181,644
Current Liabilities 4.3M 4.3M 2.7M 2.1M 1.6M
Long Term Debt -- -- 710,000 1.7M 1.7M
Long Term Debt And Capital Lease Obligation -- -- 710,000 1.7M 1.7M
Total Non Current Liabilities Net Minority Interest 0.00 0.00 710,000 1.7M 1.7M
Total Liabilities Net Minority Interest 4.3M 4.3M 3.4M 3.8M 3.3M
Common Stock 9.2M 8.5M 8.4M 7.6M 7.6M
Capital Stock 9.2M 8.5M 8.4M 7.6M 7.6M
Additional Paid In Capital -- -- -- -- --
Retained Earnings -13.3M -12.9M -11.7M -11.5M -11.0M
Gains Losses Not Affecting Retained Earnings 450,567 439,673 363,047 333,720 316,093
Common Stock Equity -3.7M -4.0M -2.9M -3.5M -3.1M
Stockholders Equity -3.7M -4.0M -2.9M -3.5M -3.1M
Total Equity Gross Minority Interest -3.7M -4.0M -2.9M -3.5M -3.1M
Total Capitalization -3.7M -4.0M -2.2M -1.8M -1.4M
Net Tangible Assets -3.7M -4.0M -2.9M -3.5M -3.1M
Tangible Book Value -3.7M -4.0M -2.9M -3.5M -3.1M
Working Capital -3.7M -4.0M -2.2M -1.8M -1.4M
Invested Capital -1.3M -1.7M -1.2M -1.8M -1.4M
Total Debt 2.3M 2.3M 1.7M 1.7M 1.7M
Net Debt 1.7M 2.2M 1.3M 1.7M 1.6M
Share Issued 57.5M 53.0M 52.2M 44.8M 44.8M
Ordinary Shares Number 57.5M 53.0M 52.2M 44.8M 44.8M
Interest Payable 321,644 286,356 251,069 216,932 181,644
Other Current Borrowings 2.3M 2.3M 1.0M -- --
Other Payable -- -- 72,875 93,525 75,375
Other Receivables -- 150,000 -- -- --
Taxes Receivable 25,086 17,549 89,933 133,128 124,840
Line Item Q4 2025Oct 31, 2025 Q3 2025Jul 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024
Operating Cash Flow -178,457 -330,145 -531,314 -26,383 -262,481
Cash Flow From Continuing Operating Activities -178,457 -330,145 -531,314 -26,383 -262,481
Stock Based Compensation 6,085 17,196 17,658 18,790 21,482
Change In Working Capital 150,221 148,025 -291,561 440,433 -5,718
Change In Receivables 142,463 -149,956 43,195 -8,288 -8,915
Change In Payables And Accrued Expense 1,881 306,729 -339,610 454,621 -5,903
Other Non Cash Items 7,500 -- -- -- --
Issuance Of Debt -- 0.00 0.00 -- --
Net Issuance Payments Of Debt -- 0.00 0.00 -- --
Issuance Of Capital Stock -- 93,750 -- -- --
Net Common Stock Issuance -- 93,750 -- -- --
Financing Cash Flow 683,138 69,984 860,800 2,625 0.00
Cash Flow From Continuing Financing Activities 683,138 69,984 860,800 2,625 0.00
Changes In Cash 504,681 -260,161 329,486 -23,758 -262,481
Beginning Cash Position 128,855 389,016 59,530 83,288 345,769
End Cash Position 633,536 128,855 389,016 59,530 83,288
Free Cash Flow -178,457 -330,145 -531,314 -26,383 -262,481
Change In Prepaid Assets 5,877 -8,748 4,854 -5,900 9,100
Common Stock Issuance -- 93,750 -- -- --
Long Term Debt Issuance -- -- 0.00 -- --
Net Income From Continuing Operations -342,263 -1.2M -257,411 -485,606 -278,245
Net Long Term Debt Issuance -- -- 0.00 -- --
Net Other Financing Charges -- -23,766 -- -- --
Net Short Term Debt Issuance -- 0.00 0.00 -- --
Proceeds From Stock Option Exercised 683,138 0.00 0.00 2,625 0.00
Short Term Debt Issuance -- 0.00 0.00 -- --
NEWS
Loading news...
TRENDING
Loading...